1995
DOI: 10.1046/j.1471-4159.1995.64052105.x
|View full text |Cite
|
Sign up to set email alerts
|

Involvement of Bidirectional Adenosine Transporters in the Release of l‐[3H]Adenosine from Rat Brain Synaptosomal Preparations

Abstract: Adenosine transport inhibitors as enhancers of extracellular levels of endogenous adenosine would, presumably, only be effective if, for example, (1) the inhibitors block influx to a greater degree than efflux (release) of intracellular adenosine or (2) the inhibitors block equally well the influx and efflux of adenosine, but significant amounts of adenosine are formed as a result of dephosphorylation of released adenine nucleotides. Limited information is available regarding the directional symmetry of adenos… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
24
0

Year Published

1998
1998
2015
2015

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 51 publications
(26 citation statements)
references
References 0 publications
2
24
0
Order By: Relevance
“…There are two sources of extracellular adenosine: release of adenosine by facilitated diffusion, through membrane adenosine transporters that are equilibrative and bidirectional (Gu et al, 1995), and extracellular conversion of released adenine nucleotides into adenosine through a series of ectoenzymes, the last one in the cascade and the rate-limiting step for adenosine formation being ecto-5Ј-nucleotidase (Zimmermann and Braun, 1999). ATP is co-stored with most neurotransmitters, and therefore neuronal activity causes the release of ATP and extracellular formation of adenosine in most brain areas, including the hippocampus (Wieraszko et al, 1989;Cunha et al, 1996).…”
Section: Discussionmentioning
confidence: 99%
“…There are two sources of extracellular adenosine: release of adenosine by facilitated diffusion, through membrane adenosine transporters that are equilibrative and bidirectional (Gu et al, 1995), and extracellular conversion of released adenine nucleotides into adenosine through a series of ectoenzymes, the last one in the cascade and the rate-limiting step for adenosine formation being ecto-5Ј-nucleotidase (Zimmermann and Braun, 1999). ATP is co-stored with most neurotransmitters, and therefore neuronal activity causes the release of ATP and extracellular formation of adenosine in most brain areas, including the hippocampus (Wieraszko et al, 1989;Cunha et al, 1996).…”
Section: Discussionmentioning
confidence: 99%
“…Unlike a classical neurotransmitter, adenosine is neither stored in synaptic vesicles nor released by exocytosis; and it does not act exclusively on synapses (Boison et al, 2010; Fredholm et al, 2005). Its release and up-take is mediated by bi-directional nucleoside transporters whereby the direction of transport solely depends on the concentration gradient between the cytoplasm and the extracellular space (Boison et al, 2010); Gu et al, 1995). Adenosine is therefore considered as a neuromodulator affecting neural activity through multiple mechanisms– presynaptically by controlling neurotransmitter release, postsynaptically by hyper- or de-polarizing neurons, and non-synaptically mainly via regulatory effects on glial cells (Boison et al, 2010).…”
Section: Adenosine: An Important Upstream Neuromodulator Of Brain mentioning
confidence: 99%
“…However, with respect to the predominant site of action of adenosine in the brain (i.e. in syn-apses), there is simply no information about which nucleoside transporters (see [103]) or which ecto-nucleotidases might be present in different types of nerve terminals (see [104]). Also, only the few studies that used isolated nerve terminals [98,[105][106][107], or fine electrophysiological techniques able to study individual synapses [78,108] or higher frequencies of stimulation [78,[108][109][110], were able to document the importance of ATP-derived adenosine as a main source of endogenous extracellular adenosine.…”
Section: C Dynamics Of the Extracellular Levels Of Adenosinementioning
confidence: 99%